Buy Aurobindo Pharma; target of Rs 850: Axis Direct News News / News 7 years ago 630 Views comments Axis Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 850 in its research report dated July 24,... Read more
News Apple iOS or Android? Here#39;s what Microsoftâs founder Bill Gates prefers on his phone News / News - 7 years ago
News Soon, new commission to examine sub-categorization of OBCs: Arun Jaitley News / News - 7 years ago
Comments